1. Home
  2. IZEA vs XBIT Comparison

IZEA vs XBIT Comparison

Compare IZEA & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IZEA Worldwide Inc.

IZEA

IZEA Worldwide Inc.

HOLD

Current Price

$3.15

Market Cap

62.9M

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.36

Market Cap

69.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IZEA
XBIT
Founded
2006
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.9M
69.8M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
IZEA
XBIT
Price
$3.15
$2.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
52.0K
32.9K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
N/A
EPS
N/A
N/A
Revenue
$20,099,695.00
N/A
Revenue This Year
$20.81
N/A
Revenue Next Year
$14.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.00
$2.09
52 Week High
$5.86
$3.61

Technical Indicators

Market Signals
Indicator
IZEA
XBIT
Relative Strength Index (RSI) 37.02 52.28
Support Level N/A $2.27
Resistance Level $3.79 $2.45
Average True Range (ATR) 0.15 0.06
MACD -0.03 0.01
Stochastic Oscillator 18.88 40.00

Price Performance

Historical Comparison
IZEA
XBIT

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: